×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PYXS – pyxis oncology, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PYXS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/20
11:10 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock, down previously from $7.00.
Medium
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock, down previously from $7.00.
12/20
10:22 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $8.00 price target on the stock, down previously from $10.00.
Medium
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $8.00 price target on the stock, down previously from $10.00.
12/19
04:11 pm
pyxs
Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201 [Yahoo! Finance]
High
Report
Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201 [Yahoo! Finance]
12/19
04:08 pm
pyxs
Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201
Medium
Report
Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201
12/1
07:38 am
pyxs
CFO & COO of Pyxis Oncology Pamela Connealy Buys 13% More Shares [Yahoo! Finance]
Low
Report
CFO & COO of Pyxis Oncology Pamela Connealy Buys 13% More Shares [Yahoo! Finance]
11/27
08:44 am
pyxs
Institutional owners may ignore Pyxis Oncology, Inc.'s (NASDAQ:PYXS) recent US$142m market cap decline as longer-term profits stay in the green [Yahoo! Finance]
Low
Report
Institutional owners may ignore Pyxis Oncology, Inc.'s (NASDAQ:PYXS) recent US$142m market cap decline as longer-term profits stay in the green [Yahoo! Finance]
11/21
10:21 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its price target raised by analysts at Royal Bank of Canada from $7.00 to $10.00. They now have an "outperform" rating on the stock.
Low
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its price target raised by analysts at Royal Bank of Canada from $7.00 to $10.00. They now have an "outperform" rating on the stock.
11/21
08:05 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
High
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/23
06:31 pm
pyxs
Form SCHEDULE 13D/A Pyxis Oncology, Inc. Filed by: Sullivan Lara
Medium
Report
Form SCHEDULE 13D/A Pyxis Oncology, Inc. Filed by: Sullivan Lara
12/23
04:33 pm
pyxs
Form 4 Pyxis Oncology, Inc. For: Dec 23 Filed by: Sullivan Lara
Low
Report
Form 4 Pyxis Oncology, Inc. For: Dec 23 Filed by: Sullivan Lara
12/23
04:30 pm
pyxs
Form 4 Pyxis Oncology, Inc. For: Dec 23 Filed by: Connealy Pamela Ann
Medium
Report
Form 4 Pyxis Oncology, Inc. For: Dec 23 Filed by: Connealy Pamela Ann
12/23
04:26 pm
pyxs
Form 4 Pyxis Oncology, Inc. For: Dec 23 Filed by: Wadhane Jitendra
Medium
Report
Form 4 Pyxis Oncology, Inc. For: Dec 23 Filed by: Wadhane Jitendra
12/19
05:08 pm
pyxs
Form 8-K Pyxis Oncology, Inc. For: Dec 19
Medium
Report
Form 8-K Pyxis Oncology, Inc. For: Dec 19
12/16
04:05 pm
pyxs
Form SCHEDULE 13G Pyxis Oncology, Inc. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Medium
Report
Form SCHEDULE 13G Pyxis Oncology, Inc. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
11/27
05:10 pm
pyxs
Form 4 Pyxis Oncology, Inc. For: Nov 26 Filed by: Connealy Pamela Ann
Medium
Report
Form 4 Pyxis Oncology, Inc. For: Nov 26 Filed by: Connealy Pamela Ann
11/20
04:08 pm
pyxs
Form 8-K Pyxis Oncology, Inc. For: Nov 20
High
Report
Form 8-K Pyxis Oncology, Inc. For: Nov 20
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: